Elizabeth Kwong

Title: Elizabeth Kwong: Innovator in Pharmaceutical Compositions

Introduction

Elizabeth Kwong is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of pharmaceuticals, particularly in the development of selective inhibitors for c-kit kinase. Her work is essential in addressing diseases associated with this kinase.

Latest Patents

Elizabeth Kwong holds a patent for "Pharmaceutical compositions of a selective c-kit kinase inhibitor and methods for making and using same." This patent relates to pharmaceutical compositions of N-(5-(5-((1R,2S)-2-fluorocyclopropyl)-1,2,4-oxadiazol-3-yl)-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide, which is useful as a selective inhibitor of c-kit kinase. The applications of this invention are crucial for the treatment of c-kit kinase associated diseases.

Career Highlights

Elizabeth is currently employed at Third Harmonic Bio, Inc., where she continues to innovate in the pharmaceutical sector. Her expertise and dedication to research have positioned her as a key player in her field.

Collaborations

Elizabeth collaborates with various professionals, including her coworker, Gregg F Keaney. Their combined efforts contribute to advancing research and development in pharmaceutical compositions.

Conclusion

Elizabeth Kwong's work in developing selective c-kit kinase inhibitors showcases her innovative spirit and commitment to improving healthcare. Her contributions are vital in the ongoing fight against diseases linked to c-kit kinase.